Dataset opportunity
Alivecor — API可访问数据集机会
由Alivecor持有的大型API可访问数据集，可用于RAG和微调。
Score
71.1
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
77%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
全球医疗保健领域人工智能（AI）市场规模在2025年估值为393.4亿美元，预计到2034年将增长至10332.7亿美元，复合年增长率（CAGR）为43.96%。
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-06-04
Can surgical robots fly? SS Innovations discusses challenges, solutions
therobotreport.com ↗ - 📰press2026-06-04
More Americans own wearables, connected health devices: survey
medtechdive.com ↗ - 📰press2026-06-04
Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs.
medtechdive.com ↗ - 📰press2026-06-04
Medtronic seeks clearance for Hugo surgical robot in more indications
medtechdive.com ↗ - 📰press2026-06-03
Edwards gets FDA approval for surgical tricuspid valve
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
API可访问数据集
Modality
多模态
Sector
医疗保健
Volume
大
Freshness
实时
Rarity
高（专有）
Accessibility
受限
Legal
混合所有权 — GDPR 敏感（PII 审查）
Buyer persona
LLM应用团队和企业搜索供应商
AliveCor 拥有一个极具价值的 API 可访问数据集，包含多模态心脏数据，主要来自其便携式 Kardia 设备收集的 ECG 描记图以及可能集成的医疗记录。这些丰富的数据，包括 35 项 FDA 批准的心脏诊断结果，非常适合 RAG 应用，使 AI 模型能够为医疗保健洞察提供上下文理解和类人交互，对于训练先进的心脏病学 AI 算法至关重要。
尽管有严格的 PHI 法规（如 HIPAA 和 GDPR）以及用户版权保留，但由于其稀有性以及在医疗保健 AI 训练中的关键作用，该数据的价值巨大。全球医疗保健多模态 AI 市场在 2024 年估值为 2.251 亿美元，预计从 2024 年到 2030 年的 CAGR 为 36.6%，而AI 心电图分析市场预计将从 2024 年的 14.0 亿美元增长到 2035 年的 98.5 亿美元，CAGR 为 19.41%。这一显著的市场增长凸显了 AI 买家对这种专业、真实世界数据的高需求，以改进诊断、药物开发和个性化患者护理。⚠ 尽职调查（有价值的数据，可协商访问）：数据包含个人健康信息 (PHI)，并受严格的隐私法规（HIPAA、GDPR）约束；用户保留其心电图数据的版权，授予 AliveCor 广泛的使用和匿名化许可，但原始数据的直接转售不属于其商业模式；数据可能集成到医疗保健提供商系统中，所有权/控制权可能转移给提供商。· 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
Alivecor 拥有一个极其稀有且专有的数据集，包含超过 2.5 亿份经过临床验证的心电图以及丰富的多模态生理数据，包括 PPG、血压、心率和药物摄入量。这些API 可访问且经 FDA 批准的数据，由在 175 万份心电图上训练的 AI 算法支持，正是 LLM 应用团队和企业搜索供应商在快速扩张的医疗保健 AI 市场中构建高度准确和可信赖的 RAG 系统所需要的。其规模、临床验证和结构化可访问性使其成为当前推动 AI 驱动医疗保健解决方案的关键资产。
See dimension details ↓- Dataset Specificity78
主导 'api'，医疗保健领域，2 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume100
12 条证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
实时/流式
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value64
适用于 RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand92
医疗保健领域的 AI 训练数据集市场，直接满足了 AI 买家和 RAG 应用的数据需求，预计到 2033 年将以约 25% 的复合年增长率 (CAGR) 增长，表明非常高的
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
开放/API 访问
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
高难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength100
5 种证据类型，12 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
所有权=混合，许可=GDPR 敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation90
4 个数据需求信号（4 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高，5 个近期外部信号 — 超出已货币化的专有数据
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit58
⚠ 审查 — Alivecor 的核心商业模式涉及通过订阅和 API/SDK 解决方案销售对专有心电图数据和 AI 驱动洞察的访问和分析，这意味着他们已经在数据/情报市场中活跃，并且不持有休眠数据。问题：Alivecor 的商业模式明确包括提供 API 和 SDK 解决方案，用于访问存储在其云端 (KardiaPro) 的患者数据并利用 AI 算法；他们的 KardiaCare 订阅服务提供高级 EK
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Knowledge base / docs
Alivecor 的知识库显示，他们的 KAI 12L AI 在来自领先医疗中心的超过 175 万份心电图上进行了训练和验证，能够检测 35 种心脏诊断结果，为企业搜索提供深入的临床验证和丰富的上下文数据。
IoT / sensor data
这一证据证实 Alivecor 已记录超过 2.5 亿份心电图，使其成为经 FDA 批准的个人心电图技术的领先提供商，也是用于高级 AI 训练的时间序列和多模态生理数据（心电图 + PPG）的宝库。
API access
Alivecor 为开发者提供强大的 API 和 SDK 解决方案，证实了对其丰富多模态数据集和集成 AI 功能的直接、结构化访问，这非常适合将数据实时集成到 LLM 应用中。
Developer portal
开发者门户强调了一个经 FDA 批准的 SDK，它允许使用 Alivecor 专有的 AI 算法安全访问和处理心电图结果，确保 RAG 系统的数据高质量和法规遵从性。
Medical records / imaging
通过与欧姆龙等公司的合作，Alivecor 展示了其收集和整合各种关键健康数据（包括血压、心率和药物摄入量）的能力，从而增强了用于 RAG 应用的潜在数据集的多模态深度。
Marketplace
Dataset details
Geographic coverage
Global
Time range
Real-time
Update frequency
Real-time
Delivery
API
License
One-time licence for API access, subject to strict PII and usage restrictions.
Personal data
Contains PII
Indicative estimate, derived from public signals — not a quote, not contractual, and not agreed with the company. Is this your company? Correct it.
This dataset's value is driven by its high rarity, proprietary nature, and critical role in training advanced AI algorithms for the rapidly growing healthcare AI market. The real-time, multimodal cardiac data, including millions of validated ECGs, is in high demand for RAG applications.
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Alivecor API-Accessible — a Large api-accessible dataset (Multimodal modality) in the healthcare domain. Primary AI use-case: RAG. Market signal: The global Artificial Intelligence (AI) in healthcare market size was valued at USD 39.34 billion in 2025 and is projected to grow to USD 1,033.27 billion by 2034, exhibiting a CAGR of 43.96%.. Investment score 71.1/100 (confidence 0.77). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Semefab — 法规记录数据集机会
View opportunity →工业Steadyenergy — 法规记录数据集机会
View opportunity →工业Radiantnuclear — 监管记录数据集机会
View opportunity →